Amlodipine-induced reversible gum hypertrophy

Amlodipine-induced reversible gum hypertrophy

Gingival hypertrophy is a common manifestation of any pathology affecting gingival and periodontal regions. It commonly follows inflammatory disorders, Vitamin C deficiency, leukemia and due to drugs such as anticonvulsants, immunosuppressants, and calcium channel blockers. Amlodipine is a third gen...

Full description

Bibliographic Details
Main Authors: Gutch Manish, Shakya Shobhit, Kumar Sukriti, Annesh Bhattacharjee, Rao Somendra Singh
Format: Article
Language:English
Published: Archives of Global Professionals 2016-01-01
Series:Archives of Pharmacy Practice
Subjects:
Amlodipine
calcium channel blockers
gingival hypertrophy
Online Access:http://www.archivepp.com/article.asp?issn=2045-080X;year=2016;volume=7;issue=3;spage=103;epage=105;aulast=Manish
id doaj-9c4a1961517a4a259b276243984bc407
record_format Article
spelling doaj-9c4a1961517a4a259b276243984bc4072020-11-24T21:51:17ZengArchives of Global ProfessionalsArchives of Pharmacy Practice2045-080X2016-01-017310310510.4103/2045-080X.186175Amlodipine-induced reversible gum hypertrophyGutch ManishShakya ShobhitKumar SukritiAnnesh BhattacharjeeRao Somendra SinghGingival hypertrophy is a common manifestation of any pathology affecting gingival and periodontal regions. It commonly follows inflammatory disorders, Vitamin C deficiency, leukemia and due to drugs such as anticonvulsants, immunosuppressants, and calcium channel blockers. Amlodipine is a third generation dihydropyridine derived calcium channel blocker commonly used to treat hypertension. Here, we describe the case of a 45-year-old hypertensive woman who was on amlodipine for 1 year and subsequently developed one of its rarest adverse effects, i.e., gingival hypertrophy.http://www.archivepp.com/article.asp?issn=2045-080X;year=2016;volume=7;issue=3;spage=103;epage=105;aulast=ManishAmlodipinecalcium channel blockersgingival hypertrophy
collection DOAJ
language English
format Article
sources DOAJ
author Gutch Manish
Shakya Shobhit
Kumar Sukriti
Annesh Bhattacharjee
Rao Somendra Singh
spellingShingle Gutch Manish
Shakya Shobhit
Kumar Sukriti
Annesh Bhattacharjee
Rao Somendra Singh
Amlodipine-induced reversible gum hypertrophy
Archives of Pharmacy Practice
Amlodipine
calcium channel blockers
gingival hypertrophy
author_facet Gutch Manish
Shakya Shobhit
Kumar Sukriti
Annesh Bhattacharjee
Rao Somendra Singh
author_sort Gutch Manish
title Amlodipine-induced reversible gum hypertrophy
title_short Amlodipine-induced reversible gum hypertrophy
title_full Amlodipine-induced reversible gum hypertrophy
title_fullStr Amlodipine-induced reversible gum hypertrophy
title_full_unstemmed Amlodipine-induced reversible gum hypertrophy
title_sort amlodipine-induced reversible gum hypertrophy
publisher Archives of Global Professionals
series Archives of Pharmacy Practice
issn 2045-080X
publishDate 2016-01-01
description Gingival hypertrophy is a common manifestation of any pathology affecting gingival and periodontal regions. It commonly follows inflammatory disorders, Vitamin C deficiency, leukemia and due to drugs such as anticonvulsants, immunosuppressants, and calcium channel blockers. Amlodipine is a third generation dihydropyridine derived calcium channel blocker commonly used to treat hypertension. Here, we describe the case of a 45-year-old hypertensive woman who was on amlodipine for 1 year and subsequently developed one of its rarest adverse effects, i.e., gingival hypertrophy.
topic Amlodipine
calcium channel blockers
gingival hypertrophy
url http://www.archivepp.com/article.asp?issn=2045-080X;year=2016;volume=7;issue=3;spage=103;epage=105;aulast=Manish
work_keys_str_mv AT gutchmanish amlodipineinducedreversiblegumhypertrophy
AT shakyashobhit amlodipineinducedreversiblegumhypertrophy
AT kumarsukriti amlodipineinducedreversiblegumhypertrophy
AT anneshbhattacharjee amlodipineinducedreversiblegumhypertrophy
AT raosomendrasingh amlodipineinducedreversiblegumhypertrophy
_version_ 1725879477532098560

Similar Items